Evidence map›Paper›PMID 20075087›Full record

ArticleAJNR. American journal of neuroradiology2010

Occurrence and predictors of futile recanalization following endovascular treatment among patients with acute ischemic stroke: a multicenter study.

H M Hussein, A L Georgiadis, G Vazquez, J T Miley, M Z Memon, Y M Mohammad, G A Christoforidis, N Tariq, A I Qureshi

8 registry-linked trialsOpen access · hybridAbstract readMulticenter Study
In one paragraph

Article in AJNR. American journal of neuroradiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 8 registered trials, which are not on this map. Cited by 98 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed, 1 pooled it
9.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05512910 phase4active not recruitingnot on this mapstarted 2023, after this paper: background citation

Minocycline for Acute Ischemic Stroke Undergoing Endovascular Treatment Due to Basilar Artery Occlusion: a Randomized, Open-label, Proof of Concept Study

TypeinterventionalSponsorXijing HospitalRan2023 to 2025Enrolled90ConditionsIschemic Stroke, Acute, Minocycline, Endovascular Treatment, Basilar Artery OcclusionArmsMinocycline
NCT05670028 phase2unknown statusnot on this mapstarted 2023, after this paper: background citation

Cerebral Hemodynamic Management Based on Cerebral Autoregulation Monitoring in Acute Ischemic Stroke Patients After Endovascular Treatment: a Multicenter, Open-label, Randomized Control Study

TypeinterventionalSponsorBeijing Tiantan HospitalRan2023 to 2026Enrolled100ConditionsIschemic Stroke, Revascularization, Blood Pressure, Cerebrovascular InsufficiencyArmsHypotensive Drugs and/or Vasoactive Drugs
NCT05836753 phase2unknown statusnot on this mapstarted 2023, after this paper: background citation

Efficacy and Safety of Sarecycline in Patients With Acute Ischemic Stroke After Reperfusion Therapy: A Phase II, Randomized, Multicenter, Double-blind, Single Dose, Placebo-controlled Parallel Trial

TypeinterventionalSponsorBeijing Tiantan HospitalRan2023 to 2023Enrolled120ConditionsIschemic Stroke, AcuteArmsSarecycline Tablet, Placebo tablets of Sarecycline tablets
NCT05836766 phase2unknown statusnot on this mapstarted 2023, after this paper: background citation

Cilostazol Dexborneol Versus Placebo for Microcirculation Dysfunction After Reperfusion Therapy in Patients With Acute Ischemic Stroke With Large Vessel Occlusion: A Phase Ⅱa,Prospective,Multicenter,Randomized, Double-blind,Placebo-controlled Parallel Trial

TypeinterventionalSponsorBeijing Tiantan HospitalRan2023 to 2024Enrolled120ConditionsAcute Ischemic Stroke, Reperfusion, Large Vessel OcclusionArmsY-6 sublingual tablets, Placebo tablets of Y-6 sublingual tablet
NCT06077305 not yet recruitingnot on this mapstarted 2023, after this paper: background citation

A Registry Study of Microcirculation Disorder After Cerebral Small Vessel Disease and Ischemic Stroke, MODEST, Research Protocol

TypeobservationalSponsorBeijing Tiantan HospitalRan2023 to 2026Enrolled20,000ConditionsCerebral Small Vessel Diseases, Ischemic Stroke
NCT06138834 phase2unknown statusnot on this mapstarted 2023, after this paper: background citation

Effects of Y-6 Sublingual Tablets for Patients With Acute Ischemic Stroke: A Phase Ⅱ, Randomized, Double-blind, Double-dummy, Placebo-controlled Parallel Trial

TypeinterventionalSponsorBeijing Tiantan HospitalRan2023 to 2025Enrolled300ConditionsAcute Ischemic Stroke, Large Vessel Occlusion, ReperfusionArmsLow-dose Y-6 sublingual tablets, High-dose Y-6 sublingual tablets, Low-dose Cilostazol, High-dose Cilostazol, Placebo
NCT07045987 enrolling by invitationnot on this mapstarted 2025, after this paper: background citation

FUtile Reperfusion in acuTe iscHEmic stRoke- FURTHER

Typeobservational_patient_registrySponsorXijing HospitalRan2025 to 2029Enrolled2,000ConditionsAcute Ischemic Stroke (AIS), Endovascular Thrombectomy, Neurovascular Unit- Brain Lymphatic System
NCT07754942 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Local-to-Systemic Inflammatory Biomarker Gradients and 90-Day Functional Outcomes in Patients With Acute Ischemic Stroke Due to Anterior Circulation Large Vessel Occlusion Undergoing Mechanical Thrombectomy: A Prospective Observational Cohort Study

TypeobservationalSponsorZhongshan Hospital Xiamen UniversityRan2026 to 2029Enrolled50ConditionsAcute Ischemic Stroke, Large Vessel OcclusionArmsProspective Mechanical Thrombectomy Cohort
3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 1 synthesis or guideline pooled it, 193 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Patient selection for mechanical thrombectomy.Clinical neuroradiology · 2014
    Trial
  4. MRI before intraarterial therapy in ischemic stroke: feasibility, impact, and safety.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2014
    Trial
  5. Endovascular treatment for acute ischemic stroke.The New England journal of medicine · 2013
    Trial
  6. Trial
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. EStroke and vascular neurology · 2025
    Article
  14. Article
  15. Article
  16. Adjunctive intra-arterial thrombolysis after thrombectomy: Findings from the RITE registry.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Observational

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

H M HusseinZeenat Qureshi Stroke Research Center, University of Minnesota, Minneapolis, Minnesota, USA. husseihm@gmail.com
A L Georgiadis
G Vazquez
J T Miley
M Z Memon
Y M Mohammad
G A Christoforidis
N Tariq
A I Qureshi
University of Minnesota · USThe Ohio State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeAlthough recanalization is the goal of thrombolysis, it is well recognized that it fails to improve outcome of acute stroke in a subset of patients. Our aim was to assess the rate of and factors associated with "futile recanalization," defined by absence of clinical benefit from recanalization, following endovascular treatment of acute ischemic stroke. MATERIALS AND

methodsData from 6 studies of acute ischemic stroke treated with mechanical and/or pharmacologic endovascular treatment were analyzed. "Futile recanalization" was defined by the occurrence of unfavorable outcome (mRS score of > or = 3 at 1-3 months) despite complete angiographic recanalization (Qureshi grade 0 or TIMI grade 3).

resultsComplete recanalization was observed in 96 of 270 patients treated with IA thrombolysis. Futile recanalization was observed in 47 (49%). In univariate analysis, patients with futile recanalization were older (73 +/- 11 versus 58 +/- 15 years, P < .0001) and had higher median initial NIHSS scores (19 versus 14, P < .0001), more frequent BA occlusion (17% versus 4%, P = .049), less frequent MCA occlusion (53% versus 76%, P = .032), and a nonsignificantly higher rate of symptomatic hemorrhagic complications (2% versus 9%, P = .2). In logistic regression analysis, futile recanalization was positively associated with age > 70 years (OR, 4.4; 95% CI, 1.9-10.5; P = .0008) and initial NIHSS score 10-19 (OR, 3.8; 95% CI, 1.7-8.4; P = .001), and initial NIHSS score > or = 20 (OR, 64.4; 95% CI, 28.8-144; P < .0001).

conclusionsFutile recanalization is a relatively common occurrence following endovascular treatment, particularly among elderly patients and those with severe neurologic deficits.

Indexed as

Acute DiseaseAdultAgedAge DistributionBrain IschemiaCerebral RevascularizationClinical Trials as TopicFemaleHumansMaleMedical FutilityMiddle AgedMultivariate AnalysisPredictive Value of TestsRadiographyRetreatment

Identifiers

PMID20075087
PMCPMC7963981
OpenAlexW2001313611

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

and 2 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.